Kenvue said it now expects annual net sales to grow closer to the lower end of its forecast of 1% to 3% growth. The consumer ...

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty ...

(Reuters) - Kenvue reported third-quarter sales marginally below Wall Street estimates on Thursday, hurt by weakness in its ...

Headlines,Institutional investors increase their stakes in Kenvue Inc.,XML Financial LLC acquires significant position in ...

Net income: US$383.0m (down 13% from 3Q 2023). Profit margin: 9.8% (down from 11% in 3Q 2023). EPS: US$0.20 (down from ...

Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Hello, and welcome to the Kenvue Third Quarter 2024 Earnings ...

Kenvue Canada Inc., a division of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), the world's largest pure-play consumer health company ...

Kenvue, Inc. ( (KVUE)) has released its Q3 earnings. Here is a breakdown of the information Kenvue, Inc. presented to its investors. Kenvue, Inc., the world’s largest pure-play consumer health company ...

Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...

The Neutrogena owner has named former Hydrafacial and Coty exec Stanleick as President, Skin Health & Beauty for North ...

Kenvue reports Q3 sales of $3.89 billion, slightly missing estimates. Strong growth in Essential Health offsets declines in ...

Negative blocking isn’t the healthiest – or the most efficient – way to approach brand safety, says Kenvue's Mark Proulx.